pharmaceutical industry

  1. S

    Andhra Plant Receives Satisfactory Inspection Report from USFDA

    New Delhi, March 12 Aurobindo Pharma announced on Thursday that it has received an inspection report from the US health regulator, classifying its wholly-owned subsidiary's manufacturing unit in Andhra Pradesh as having a "Voluntary Action Indicated" (VAI) classification, which indicates...
  2. G

    Saccharin Imports: Countervailing Duty Probe Launched

    New Delhi, March 12 India has started an investigation into alleged circumvention of countervailing duties imposed on saccharin—used in various industries such as food, beverage, and pharmaceuticals—imported from China, according to a notification.The investigation was initiated by the...
  3. S

    Pharmaceuticals: India’s API Exports Rise Above Imports

    New Delhi, March 10 Chemicals and Fertilizers Minister J P Nadda said on Tuesday that India's exports of active pharmaceutical ingredients (APIs) stood at around Rs 41,500 crore in the last fiscal, higher than the total imports of Rs 39,215 crore.Responding to a supplementary query during the...
  4. A

    FTAs Boost Pharma and Healthcare Export Opportunities

    New Delhi, March 9 The nine free trade agreements (FTAs) finalized by India in the last four years will provide significant business opportunities for the domestic pharmaceutical and healthcare sectors, Commerce and Industry Minister Piyush Goyal said on Monday.India has finalized FTAs with...
  5. T

    India's FTAs: New Export Opportunities for Healthcare

    New Delhi, March 9 The nine free trade agreements (FTAs) finalized by India over the past four years will provide significant business opportunities for the domestic pharmaceutical and healthcare sectors, Commerce and Industry Minister Piyush Goyal said on Monday.India has finalized FTAs with...
  6. N

    FDA Director Vinay Prasad Steps Down Amid Regulatory Changes

    New York, March 8 – Indian-American scientist Vinay Prasad, who oversees the approval process for vaccines and new therapies, is stepping down amid controversy over his decisions to tighten certain regulations. His departure from his position as director of the Food and Drug Administration's...
  7. S

    Cipla Recalls Cancer Drug Over Manufacturing Issues

    New Delhi, March 8 A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).Cipla USA, Inc, based in Warren (New Jersey), is recalling Nilotinib Capsules in...
  8. A

    CM Mann Unveils Flexible Industrial Incentives for Punjab Businesses

    Ludhiana, March 7 Punjab Chief Minister Bhagwant Mann on Saturday unveiled a new industrial policy here, asserting that his government is determined to make the state the number one investment destination in the country through bold reforms and a flexible incentive framework designed around the...
  9. P

    India's Pharma Industry Grapples with Rising Freight Costs and Supply Disruptions

    New Delhi, March 5 The domestic pharmaceutical industry is facing potential losses ranging from Rs 2,500 crore to Rs 5,000 crore due to various supply and freight disruptions caused by the conflict in the Middle East, according to the Pharmaceuticals Export Promotion Council of India...
  10. P

    Government Initiatives for India's Pharmaceutical and Chemical Industries

    Minister of Chemicals and Fertilizers, Jagat Prakash Nadda, stated that the budgetary allocation of 13 thousand crore rupees for BioPharma SHAKTI and three dedicated Chemical Parks is a strategic investment in India's future. Speaking at the post-Budget webinar on the theme "Sustaining and...
  11. S

    Sodium Phosphate Injection Market Sees $66.8M Annual Sales – Glenmark to Enter

    New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
  12. A

    Maharashtra GST Department Inspects Lupin Office

    New Delhi, February 25 Pharmaceutical company Lupin Ltd announced on Wednesday that the Maharashtra GST Department has initiated an inspection and search at its registered office in Mumbai.The inspection and search, which began at 11:50 am on February 25, 2026, is aimed at obtaining documents...
  13. P

    Lupin Launches Generic Seizure Treatment in the US

    New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
  14. A

    Market Opportunity for Efinaconazole as Alembic Pharma Gains USFDA Nod

    New Delhi, February 24 Alembic Pharmaceuticals announced on Tuesday that it has received approval from the US health regulator to market a generic antifungal medication.The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution...
  15. N

    Cough Syrup Manufacturing Issues Addressed Through Increased Regulatory Oversight

    Mumbai, February 23 The Central Drugs Standard Control Organisation (CDSO) has conducted an audit of almost 90 per cent of cough syrup manufacturers in the country, and it hopes to eliminate the "problem" in cough syrup by the next season, a top official said on Monday.Speaking at the 11th...
  16. D

    India Aims to Lead Global Pharma Supply Chain with Quality and Innovation

    Mumbai, February 23 Union Minister J P Nadda on Monday urged the domestic pharmaceutical industry to anchor the redesigned global supply chain not only with scale, but also with quality, reliability, and innovation.Addressing virtually the 11th edition of the Global Pharmaceutical Quality...
  17. D

    India's Growing Role in Global Pharma Market: Export Figures and Future Plans

    New Delhi, February 21 The commerce ministry said on Saturday that the country's pharmaceutical exports grew by 9.4 per cent in 2024-25 to USD 30.47 billion, and the industry is aiming for double-digit expansion in 2026-27.Issues related to pharmaceutical exports were discussed between...
  18. B

    Trump's Trade Leverage: Wine Tariff as a Negotiation Tactic

    Washington, February 20 – President Donald Trump said he threatened to impose a 100% tariff on French wine and champagne in order to force changes in global drug pricing, offering a vivid example of how he uses trade leverage to reshape international economic arrangements.Speaking at a steel...
  19. K

    USFDA Inspection Reveals Six Observations at Alkem's Chakan Plant

    New Delhi, February 16 Alkem Laboratories said on Monday that the US health regulator has issued a Form 483 with six observations after inspecting the manufacturing unit of its wholly-owned subsidiary, located in Chakan.The US Food and Drug Administration (USFDA) completed a pre-approval...
  20. K

    India's Ayush Sector Gains Momentum with First Homeopathic NABL Certification

    New Delhi, February 15 Pharmaceutical firm Adven Biotech has claimed to be the first homeopathy brand in the country to receive certification from the National Accreditation Board for Testing and Calibration Laboratories (NABL), further strengthening India's efforts to achieve global-quality...
Back
Top